PRESS RELEASE published on 10/29/2025 at 18:30, 1 year ago Inside Information / News release on accounts, results Theraclion reports successful pivotal study, CE certification, GB 9706.1-2020 certification; 89% revenue increase and 23% operating loss reduction in 2025 half-year results Revenue Increase Operating Loss Reduction CE Certification Pivotal Study Theraclion
BRIEF published on 10/21/2025 at 18:35, 1 year ago Theraclion obtains crucial certification in China Medical Theraclion SONOVEIN® Focused Ultrasound Chinese Certification
BRIEF published on 10/10/2025 at 18:35, 1 year ago Monthly publication of Theraclion voting rights Share Capital Voting Rights Investment Euronext Growth Theraclion
PRESS RELEASE published on 10/10/2025 at 18:30, 1 year ago Inside Information / Other news releases Theraclion provides monthly update on total voting rights and shares. The French MedTech company uses focused ultrasound for non-invasive treatment. CE-marked platform SONOVEIN® targets varicose veins Voting Rights Shares Theraclion SONOVEIN Focused Ultrasound
BRIEF published on 09/15/2025 at 18:35, 1 year 1 month ago Theraclion Successfully Completes Pivotal Study with 96.8% Occlusion Rate FDA Clinical Trial Theraclion SONOVEIN® Varicose Veins
PRESS RELEASE published on 09/15/2025 at 18:30, 1 year 1 month ago Inside Information / Other news releases Theraclion announces successful U.S. FDA pivotal study showing 96.8% occlusion rate with Sonovein® for varicose vein treatment. Results support potential U.S. market entry Theraclion SONOVEIN® U.S. FDA Study Varicose Vein Treatment Occlusion Rate
BRIEF published on 07/25/2025 at 18:35, 1 year 3 months ago Theraclion in full expansion in the first half of 2025 Financial Results Clinical Trials Business Expansion Theraclion SONOVEIN
PRESS RELEASE published on 07/25/2025 at 18:30, 1 year 3 months ago Inside Information / News release on accounts, results Theraclion reports strong growth in S1 2025 with increased revenue and expansion into new markets. Key achievements include 30% rise in consumables sales and completion of pivotal FDA clinical trial follow-up period Revenue Growth Business Expansion Theraclion FDA Clinical Trial S1 2025
BRIEF published on 07/09/2025 at 18:35, 1 year 3 months ago Review of the first half of 2025 of the Theraclion liquidity contract Liquidity Contract Half-yearly Report Euronext Growth Theraclion Securities Traded
BRIEF published on 02/20/2025 at 18:35, 1 year 8 months ago Theraclion secures financing via a convertible bond issue Convertible Bonds Funding Business Strategy Theraclion R&D And FDA
Published on 11/06/2026 at 13:00, 2 hours 24 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 hours 54 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 hours 54 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 05:15, 10 hours 9 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 14:50, 33 minutes ago New UN guide keeps people in charge of AI in smart cities
Published on 11/06/2026 at 14:45, 39 minutes ago Ningbo Consensus on Collaborative Development released at 2026 Global Mayors Dialogue · Ningbo
Published on 11/05/2026 at 18:21, 21 hours 2 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 17:45, 21 hours 39 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 11/05/2026 at 17:29, 21 hours 54 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN FR0010406082
